Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126298481 | 12629848 | 1 | I | 20160728 | 20160808 | 20160808 | EXP | GB-MHRA-EYC 00142881 | GB-TEVA-681667ACC | TEVA | 0.00 | M | Y | 0.00000 | 20160808 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126298481 | 12629848 | 1 | PS | DIAZEPAM. | DIAZEPAM | 1 | Oral | 2 MILLIGRAM DAILY; AT NIGHT | Y | U | 70152 | 2 | MG | QD | |||||
| 126298481 | 12629848 | 2 | SS | PREGABALIN. | PREGABALIN | 1 | Oral | 150 MILLIGRAM DAILY; | Y | U | 0 | 75 | MG | BID | |||||
| 126298481 | 12629848 | 3 | SS | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 400 MICROGRAM DAILY; | Y | U | 77630 | 400 | UG | QD | |||||
| 126298481 | 12629848 | 4 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 100 MILLIGRAM DAILY; AT NIGHT | Y | U | 71523 | 100 | MG | QD | |||||
| 126298481 | 12629848 | 5 | SS | OXYCODONE | OXYCODONE | 1 | Oral | 30 MILLIGRAM DAILY; | Y | U | 0 | 15 | MG | BID | |||||
| 126298481 | 12629848 | 6 | SS | OXYCODONE | OXYCODONE | 1 | Oral | ADDITIONAL 10MG EVERY 4 HOURS | Y | U | 0 | 10 | MG | ||||||
| 126298481 | 12629848 | 7 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 9 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 10 | C | CARBOCISTEINE | CARBOCYSTEINE | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 11 | C | DOCUSATE | DOCUSATE | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 12 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 13 | C | LIDOCAINE. | LIDOCAINE | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 14 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 15 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 16 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 17 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 18 | C | SALBUTAMOL | ALBUTEROL | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 19 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 20 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 126298481 | 12629848 | 21 | C | THIAMINE. | THIAMINE | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126298481 | 12629848 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126298481 | 12629848 | Circulatory collapse | |
| 126298481 | 12629848 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |